Rosebud O Roberts1, Ruth H Cha2, Michelle M Mielke2, Yonas E Geda2, Bradley F Boeve2, Mary M Machulda2, David S Knopman2, Ronald C Petersen2. 1. From the Divisions of Epidemiology (R.O.R., M.M. Mielke, Y.E.G., R.C.P.) and Biomedical Statistics and Informatics (R.H.C.), Department of Health Sciences Research, the Department of Neurology (R.O.R., B.F.B., D.S.K., R.C.P.), and the Department of Psychiatry and Psychology (M.M. Machulda), Mayo Clinic, Rochester, MN; and the Departments of Psychiatry and Psychology and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ. roberts.rosebud@mayo.edu. 2. From the Divisions of Epidemiology (R.O.R., M.M. Mielke, Y.E.G., R.C.P.) and Biomedical Statistics and Informatics (R.H.C.), Department of Health Sciences Research, the Department of Neurology (R.O.R., B.F.B., D.S.K., R.C.P.), and the Department of Psychiatry and Psychology (M.M. Machulda), Mayo Clinic, Rochester, MN; and the Departments of Psychiatry and Psychology and Neurology (Y.E.G.), Mayo Clinic, Scottsdale, AZ.
Abstract
OBJECTIVE: To determine risk and protective factors for mild cognitive impairment (MCI) among persons 85 years and older. METHODS: Participants in the population-based prospective Mayo Clinic Study of Aging were comprehensively evaluated at baseline and at 15 monthly intervals to determine incident MCI. At baseline, lifestyle factors in midlife and late life were assessed by self-reported questionnaire; vascular and comorbid conditions were abstracted from participants' medical records. RESULTS: Of 256 participants who were cognitively normal at enrollment (median age 87.3 years, 62% women), 121 developed MCI at a median 4.1 years of follow-up. Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive symptoms (HR 1.78; p = 0.02), midlife onset of hypertension (HR 2.43; p = 0.005), increasing number of vascular diseases (HR 1.13; p = 0.02), and chronic conditions from the Charlson Comorbidity Index (HR 1.08; p = 0.006). Models were adjusted for sex and education, with age as the time variable. The risk of MCI was reduced for participants who reported engagement in artistic (HR 0.27; p = 0.03), craft (HR 0.55; p = 0.02), and social (HR 0.45; p = 0.005) activities in both midlife and late life, and in the use of a computer in late life (HR 0.47; p = 0.008). CONCLUSIONS: Chronic disease burden increases risk of MCI, whereas certain lifestyle factors reduce risk in persons 85 years and older. This implies that preventive strategies for MCI may need to begin in midlife and should persist throughout late life.
OBJECTIVE: To determine risk and protective factors for mild cognitive impairment (MCI) among persons 85 years and older. METHODS:Participants in the population-based prospective Mayo Clinic Study of Aging were comprehensively evaluated at baseline and at 15 monthly intervals to determine incident MCI. At baseline, lifestyle factors in midlife and late life were assessed by self-reported questionnaire; vascular and comorbid conditions were abstracted from participants' medical records. RESULTS: Of 256 participants who were cognitively normal at enrollment (median age 87.3 years, 62% women), 121 developed MCI at a median 4.1 years of follow-up. Predictors of MCI were APOE ε4 allele (hazard ratio [HR] 1.89; p = 0.008), current depressive symptoms (HR 1.78; p = 0.02), midlife onset of hypertension (HR 2.43; p = 0.005), increasing number of vascular diseases (HR 1.13; p = 0.02), and chronic conditions from the Charlson Comorbidity Index (HR 1.08; p = 0.006). Models were adjusted for sex and education, with age as the time variable. The risk of MCI was reduced for participants who reported engagement in artistic (HR 0.27; p = 0.03), craft (HR 0.55; p = 0.02), and social (HR 0.45; p = 0.005) activities in both midlife and late life, and in the use of a computer in late life (HR 0.47; p = 0.008). CONCLUSIONS: Chronic disease burden increases risk of MCI, whereas certain lifestyle factors reduce risk in persons 85 years and older. This implies that preventive strategies for MCI may need to begin in midlife and should persist throughout late life.
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Joshua J Pankratz; Scott M Brue; Walter A Rocca Journal: Int J Epidemiol Date: 2012-11-18 Impact factor: 7.196
Authors: D I Kaufer; J L Cummings; P Ketchel; V Smith; A MacMillan; T Shelley; O L Lopez; S T DeKosky Journal: J Neuropsychiatry Clin Neurosci Date: 2000 Impact factor: 2.198
Authors: Szofia S Bullain; Maria M Corrada; Barbara Agee Shah; Farah H Mozaffar; Martina Panzenboeck; Claudia H Kawas Journal: JAMA Neurol Date: 2013-01 Impact factor: 18.302
Authors: Stephen R Rapp; Mark A Espeland; Joann E Manson; Susan M Resnick; Nick R Bryan; Sylvia Smoller; Laura H Coker; Lawrence S Phillips; Marcia L Stefanick; Gloria E Sarto Journal: Int J Psychiatry Med Date: 2013 Impact factor: 1.210
Authors: Yonas E Geda; Rosebud O Roberts; David S Knopman; Teresa J H Christianson; V Shane Pankratz; Robert J Ivnik; Bradley F Boeve; Eric G Tangalos; Ronald C Petersen; Walter A Rocca Journal: Arch Neurol Date: 2010-01
Authors: David S Knopman; Rosebud O Roberts; Yonas E Geda; Bradley F Boeve; V Shane Pankratz; Ruth H Cha; Eric G Tangalos; Robert J Ivnik; Ronald C Petersen Journal: Arch Neurol Date: 2009-05
Authors: Maria Vassilaki; Jeremiah A Aakre; Walter K Kremers; Michelle M Mielke; Yonas E Geda; Mary M Machulda; David S Knopman; Preciosa M Coloma; Barbara Schauble; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen; Rosebud O Roberts Journal: J Am Geriatr Soc Date: 2018-11-21 Impact factor: 5.562
Authors: Jonathan Graff-Radford; Mekala R Raman; Alejandro A Rabinstein; Scott A Przybelski; Timothy G Lesnick; Bradley F Boeve; Melissa E Murray; Dennis W Dickson; R Ross Reichard; Joseph E Parisi; David S Knopman; Ronald C Petersen; Clifford R Jack; Kejal Kantarci Journal: JAMA Neurol Date: 2018-02-01 Impact factor: 18.302
Authors: Janina Krell-Roesch; Prashanthi Vemuri; Anna Pink; Rosebud O Roberts; Gorazd B Stokin; Michelle M Mielke; Teresa J H Christianson; David S Knopman; Ronald C Petersen; Walter K Kremers; Yonas E Geda Journal: JAMA Neurol Date: 2017-03-01 Impact factor: 18.302
Authors: Marcello Tonelli; Natasha Wiebe; Sharon Straus; Martin Fortin; Bruce Guthrie; Matthew T James; Scott W Klarenbach; Helen Tam-Tham; Richard Lewanczuk; Braden J Manns; Hude Quan; Paul E Ronksley; Peter Sargious; Brenda Hemmelgarn Journal: CMAJ Open Date: 2017-08-14
Authors: Rebecca K West; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Derek Leroith; Keren Koifman; Ryan C N D'Arcy; Xiaowei Song; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Mary Sano; Jeremy M Silverman; Michal Schnaider-Beeri Journal: Alzheimers Dement Date: 2016-05-02 Impact factor: 21.566
Authors: Maria Vassilaki; Jeremy A Syrjanen; Walter K Kremers; Philip T Hagen; David S Knopman; Michelle M Mielke; Yonas E Geda; Rabe E Alhurani; Mary M Machulda; Rosebud O Roberts; Ronald C Petersen Journal: J Am Geriatr Soc Date: 2020-02-22 Impact factor: 5.562